The Center for Forensic Science Research and Education (CFSRE) operates an open-access drug early warning system called NPS Discovery. Through this initiative, the CFSRE is able to offer non-routine, no-cost comprehensive forensic chemistry and toxicology testing for emerging drugs and novel psychoactive substances (NPS), including qualitative and quantitative reporting. Our laboratory accepts biological specimens (e.g., blood, urine, serum, plasma,) and drug materials (e.g., pills, powder, plant materials), among other sample types upon request. For more information and/or to inquire about testing opportunities, please contact our program director Dr. Alex Krotulski (
This email address is being protected from spambots. You need JavaScript enabled to view it.).
BENEFITS OF FORENSIC TESTING AT THE CFSRE:
- Perform routine testing for all NPS subclasses, including opioids, benzodiazepines, stimulants, hallucinogens, and cannabinoids.
- Assist medical examiners and coroners with determining cause of death when prior toxicology testing is negative or inconclusive.
- Analysis by state-of-the-art instrumentation and methodologies.
- Regularly updated, comprehensive in-house library database containing more than 1,200 drugs.
- Sample handling and analysis performed under chain of custody.
- Forensic quality data and individual reports generated per case.
- World-leading forensic toxicologists, chemists, and scientists.
- Laboratory follows forensic and industry best practices.
